Search

everythinglearnresearchcommunity

for

Search:↓

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Vitamin B5 and coenzyme A may help regulate the immune system and could improve treatments for chronic diseases and cancer.

CD80 on skin stem cells helps expand Treg cells to aid wound healing.

Replacing defective mesenchymal cells with normal ones fixes thymic growth issues in 22q11.2DS mouse models.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Hit15 shows promise as a COVID-19 treatment by reducing virus infection and inflammation.

Increasing type 17 collagen reduces aging signs in skin cells caused by UV light.

Vesiculobullous lesions should be considered part of canine cutaneous epitheliotropic T-cell lymphoma.

CLEC10A and interleukin-42 can help identify PCOS patients' response to Metformin treatment.

A new treatment may prevent hair loss from chemotherapy by normalizing scalp cell death and reducing inflammation.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Different γδ T cell types have unique roles in causing alopecia areata.

Notch signaling is crucial for specifying niche cells in Drosophila testis.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Keratin 19 expression in certain skin cells is temporary and not a reliable stem cell marker.

TCDD disrupts skin stem cells, causing skin issues like chloracne.

Blocking IL-17 can reduce skin inflammation in a mouse model of pityriasis rubra pilaris.

CAR-T cell therapy shows promise for treating autoimmune disorders but faces challenges like complex manufacturing and limited tissue penetration.

PX-12 may help treat psoriasis by blocking inflammation and cell death.

Disrupting Bcl-xL in mice reduces skin cancer risk.

Microarray analysis helps find hidden chromosomal changes in patients with intellectual disabilities and birth defects.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

The treatment was effective for advanced non-Hodgkin's lymphomas.

LGR5 and LGR6 are expressed differently in various skin tumors, which may offer clues about their origins.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

The study developed a mouse model for Alopecia Areata that responds to treatment, useful for future research.